Media coverage about Bruker Corporation (NASDAQ:BRKR) has trended somewhat positive recently, Alpha One reports. Alpha One, a unit of Accern, identifies positive and negative news coverage by reviewing more than 20 million blog and news sources in real time. Alpha One ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Bruker Corporation earned a coverage optimism score of 0.17 on Alpha One’s scale. Alpha One also gave news stories about the medical research company an impact score of 62 out of 100, indicating that recent news coverage is somewhat likely to have an impact on the stock’s share price in the near term.
These are some of the media headlines that may have effected AlphaOne’s analysis:
- Tenneco Inc. (TEN) Shares Sold by Meeder Asset Management Inc (hoyentv.com)
- Insider Selling: Bruker Corporation (BRKR) Director Sells 19,900 Shares of Stock (americanbankingnews.com)
- Cisco Systems, Inc. (NASDAQ:CSCO) Continuing to Trade Below Moving Averages (joshnaijablog.com)
- Bruker Corporation (BRKR) Reached a 52-Week High (highlightpress.com)
- Bruker Corporation (BRKR) Director Sells $677,520.00 in Stock (americanbankingnews.com)
Bruker Corporation (BRKR) traded down 0.14% on Friday, hitting $27.71. 880,321 shares of the stock were exchanged. The stock has a market cap of $4.43 billion, a price-to-earnings ratio of 29.42 and a beta of 1.02. Bruker Corporation has a 12 month low of $19.58 and a 12 month high of $28.35. The company has a 50-day moving average of $26.54 and a 200-day moving average of $23.87.
Bruker Corporation (NASDAQ:BRKR) last announced its quarterly earnings results on Wednesday, May 3rd. The medical research company reported $0.19 EPS for the quarter, hitting analysts’ consensus estimates of $0.19. Bruker Corporation had a net margin of 9.35% and a return on equity of 26.88%. The firm had revenue of $384.90 million during the quarter, compared to analyst estimates of $372.59 million. During the same period in the previous year, the business posted $0.21 earnings per share. The business’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, equities analysts predict that Bruker Corporation will post $1.10 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, June 23rd. Stockholders of record on Monday, June 5th will be paid a $0.04 dividend. The ex-dividend date is Thursday, June 1st. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.58%. Bruker Corporation’s dividend payout ratio is presently 17.02%.
A number of equities research analysts have issued reports on BRKR shares. Janney Montgomery Scott downgraded shares of Bruker Corporation from a “buy” rating to a “neutral” rating in a research report on Monday, March 27th. Cleveland Research raised shares of Bruker Corporation from a “neutral” rating to a “buy” rating in a research report on Thursday, April 27th. Cowen and Company upped their price objective on shares of Bruker Corporation from $25.00 to $27.00 and gave the stock a “market perform” rating in a research report on Thursday, May 4th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $29.00 price objective on shares of Bruker Corporation in a research report on Friday, May 5th. Finally, Deutsche Bank AG upped their price objective on shares of Bruker Corporation from $25.00 to $27.00 and gave the stock a “hold” rating in a research report on Friday, May 5th. Twelve research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $25.00.
In related news, Director Ingen Chris Van sold 19,900 shares of the business’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $28.03, for a total transaction of $557,797.00. Following the completion of the sale, the director now directly owns 14,577 shares in the company, valued at $408,593.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Frank H. Laukien bought 73,000 shares of the business’s stock in a transaction that occurred on Thursday, May 18th. The shares were acquired at an average price of $26.22 per share, with a total value of $1,914,060.00. Following the completion of the transaction, the chief executive officer now directly owns 37,750,851 shares of the company’s stock, valued at approximately $989,827,313.22. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 78,120 shares of company stock valued at $2,047,366 and sold 117,624 shares valued at $3,271,574. Insiders own 35.80% of the company’s stock.
Bruker Corporation Company Profile
Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions that enable its customers to explore life and materials at microscopic, molecular and cellular levels. The Company’s segments include Bruker Scientific Instruments (BSI) and Bruker Energy & Supercon Technologies (BEST).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2229179/bruker-corporation-brkr-given-daily-media-impact-score-of-0-17.html
Receive News & Ratings for Bruker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.